News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,668 Results
Type
Article (14334)
Company Profile (283)
Press Release (257051)
Section
Business (80784)
Career Advice (154)
Deals (13504)
Drug Delivery (35)
Drug Development (51154)
Employer Resources (31)
FDA (5869)
Job Trends (5271)
News (146860)
Policy (10260)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (922)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21886)
ALS (61)
Alzheimer's disease (844)
Antibody-drug conjugate (ADC) (89)
Approvals (5892)
Artificial intelligence (114)
Autoimmune disease (13)
Automation (5)
Bankruptcy (106)
Best Places to Work (4700)
BIOSECURE Act (5)
Biosimilars (42)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (142)
Cancer (1341)
Cardiovascular disease (112)
Career advice (133)
Career pathing (2)
CAR-T (107)
Cell therapy (309)
Cervical cancer (8)
Clinical research (41542)
Collaboration (502)
Compensation (235)
Complete response letters (13)
COVID-19 (1039)
CRISPR (37)
C-suite (147)
Cystic fibrosis (77)
Data (1390)
Denatured (11)
Depression (29)
Diabetes (127)
Diagnostics (1357)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (30464)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (49157)
Executive appointments (412)
FDA (6510)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (476)
Gene editing (89)
Generative AI (9)
Gene therapy (235)
GLP-1 (359)
Government (1091)
Grass and pollen (2)
Guidances (20)
Healthcare (6729)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (81)
Indications (18)
Infectious disease (1104)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (58)
Interviews (17)
IPO (7400)
IRA (11)
Job creations (871)
Job search strategy (128)
Kidney cancer (6)
Labor market (4)
Layoffs (204)
Leadership (2)
Legal (1406)
Liver cancer (31)
Lung cancer (194)
Lymphoma (88)
Machine learning (1)
Management (7)
Manufacturing (117)
MASH (49)
Medical device (2714)
Medtech (2715)
Mergers & acquisitions (6402)
Metabolic disorders (367)
Multiple sclerosis (52)
NASH (13)
Neurodegenerative disease (61)
Neuropsychiatric disorders (23)
Neuroscience (1222)
NextGen: Class of 2025 (2069)
Non-profit (866)
Northern California (1594)
Now hiring (21)
Obesity (186)
Opinion (100)
Ovarian cancer (61)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (111)
Partnered (9)
Patents (112)
Patient recruitment (67)
Peanut (35)
People (25756)
Pharmaceutical (49)
Pharmacy benefit managers (5)
Phase I (14601)
Phase II (19252)
Phase III (12318)
Pipeline (753)
Podcasts (47)
Policy (38)
Postmarket research (878)
Preclinical (6113)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (278)
Real estate (1442)
Recruiting (12)
Regulatory (8780)
Reports (15)
Research institute (944)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (11)
Schizophrenia (56)
Series A (92)
Series B (61)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1408)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1986)
State (1)
Stomach cancer (4)
Supply chain (18)
Tariffs (3)
The Weekly (35)
United States (12489)
Vaccines (211)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (67)
Last 7 days (453)
Last 30 days (1666)
Last 365 days (20340)
2025 (5020)
2024 (20916)
2023 (22786)
2022 (27315)
2021 (28175)
2020 (23750)
2019 (16600)
2018 (11998)
2017 (13966)
2016 (12079)
2015 (14683)
2014 (10579)
2013 (7614)
2012 (7698)
2011 (7787)
2010 (7572)
Location
Africa (149)
Alabama (38)
Alaska (2)
Arizona (66)
Arkansas (5)
Asia (17718)
Australia (2985)
California (3613)
Canada (1071)
China (329)
Colorado (138)
Connecticut (152)
Delaware (90)
Europe (37592)
Florida (433)
Georgia (110)
Idaho (16)
Illinois (219)
India (9)
Indiana (95)
Iowa (1)
Japan (75)
Kansas (59)
Kentucky (7)
Louisiana (3)
Maine (11)
Maryland (453)
Massachusetts (2838)
Michigan (72)
Minnesota (146)
Mississippi (1)
Missouri (27)
Montana (14)
Nebraska (4)
Nevada (16)
New Hampshire (14)
New Jersey (918)
New Mexico (12)
New York (992)
North Carolina (527)
North Dakota (4)
Northern California (1594)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (682)
Puerto Rico (3)
Rhode Island (15)
South America (213)
South Carolina (4)
Southern California (1408)
Tennessee (27)
Texas (435)
Utah (48)
Virginia (71)
Washington D.C. (28)
Washington State (324)
Wisconsin (15)
271,668 Results for "tp therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
February 19, 2025
·
3 min read
Press Releases
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
December 25, 2024
·
6 min read
Genetown
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced the presentation of updated exploratory subgroup analyses from the SIENDO study, in patients with advanced or recurrent TP53 wild-type endometrial cancer at the 2024 American Society of Clinical Oncology Annual Meeting.
June 1, 2024
·
17 min read
Drug Development
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) AML Patients at the EHA 2024 Congress
Shattuck Labs, Inc., a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, announced the presentation of additional data from the Phase 1B dose expansion clinical trial of SL-172154 with AZA in frontline HR-MDS and TP53m AML patients.
May 14, 2024
·
7 min read
Genetown
Affini-T Therapeutics to Present Data From Its Preclinical Programs Targeting KRAS G12D and TP53 R175H at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Affini-T Therapeutics, Inc. today announced that data from its preclinical gene edited HLA-A*11:01 KRAS G12D (AFNT-212) and HLA-A*02:01 TP53 R175H T Cell Receptor (TCR) T cell therapy products for the treatment of solid cancers will be presented at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting held in Baltimore, MD May 7-11.
May 1, 2024
·
3 min read
Drug Development
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) & TP53 mutant AML Patients
Shattuck Labs, Inc. announced updated interim data from the Phase 1B dose expansion clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients.
June 14, 2024
·
11 min read
Press Releases
Thetis Pharmaceuticals Announces Positive Initial Results From Phase 1a Study of TP-317 in Healthy Subjects
October 31, 2024
·
2 min read
Press Releases
Thetis Pharmaceuticals Secures an Additional $8.975 Million in Program-Related Investment Funds from the Helmsley Charitable Trust to Advance TP-317, an Oral BLT1 Agonist, into a Phase 1b Trial in Ulcerative Colitis Patients
January 9, 2025
·
3 min read
Drug Development
Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease
Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced positive topline results from the Phase 2a Carpo trial evaluating TP-05, a novel, investigational oral therapeutic for the prevention of Lyme disease.
February 22, 2024
·
6 min read
Press Releases
Affini-T Therapeutics to Present Trial-in-Progress Poster and Preclinical Data from Its Oncogenic Driver Programs Targeting TP53 R175H, KRAS G12D and KRAS-G12V at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
November 6, 2024
·
4 min read
1 of 27,167
Next